Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 61 - 75 of 180 items.
Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contamination
AlertPublic advisory | 2022-08-06
Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity
AlertPublic advisory | 2022-07-28
Buying health products online? Know the risks
AlertPublic advisory | 2022-07-20
Unauthorized health products seized from three herbal medicine stores in Calgary, Alberta
AlertPublic advisory | 2022-06-16
Unauthorized products may pose serious health risks (March 26, 2021 to June 3, 2022)
AlertPublic advisory | 2022-06-03
Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
AlertPublic advisory | 2022-04-21
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
AlertHealth professional risk communication | 2022-04-14
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
AlertHealth professional risk communication | 2022-03-15
0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
AlertHealth professional risk communication | 2022-03-09
Pfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosamine impurity
AlertPublic advisory | 2022-03-01
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17